Literature DB >> 9757091

Structures of monoclinic lysozyme iodide at 1.6 A and of triclinic lysozyme nitrate at 1.1 A.

L K Steinrauf1.   

Abstract

Hen egg-white lysozyme is one of the most thoroughly studied of enzymes and has been the subject of study by many methods, including X-ray crystallography. The present work extends the X-ray crystallography to higher resolution, includes the positions of the anions, and examines the contacts of the neighbors in greater detail. Data were collected at room temperature on a Rigaku R-axis area detector with rotating-anode X-ray generator to 1.6 A resolution for monoclinic lysozyme iodide at pH 4.0, to 1.8 A for monoclinic lysozyme iodide at pH 8.0, and to 1.1 A resolution for triclinic lysozyme nitrate at pH 4.5. The structures have been refined by SHELX93 with the expected number of anion sites being accounted for. Two regions of the protein have been found to be variable: residues 65-75 and 99-104. Except for 65-75 and 99-104, lysozyme is a very stable molecule with the crystal forms being held together by the electrostatic contacts of the anions and by layers of water molecules. The anion positions can be described as paired half sites, each half being contributed by a different lysozyme molecule. The many different crystal forms of lysozyme may be due to different combinations of the many such half sites on the surface. A hypothesis is presented for lysozyme in the different crystal forms and which may be extended to behavior in solution. Suggestions for future crystallographic research are proposed, involving anions of different shape and charge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757091     DOI: 10.1107/s0907444997016922

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  8 in total

1.  Mapping site-specific changes that affect stability of the N-terminal domain of calmodulin.

Authors:  Mary E Krause; Talia T Martin; Jennifer S Laurence
Journal:  Mol Pharm       Date:  2012-02-15       Impact factor: 4.939

2.  Asparagine and glutamine side-chain conformation in solution and crystal: a comparison for hen egg-white lysozyme using residual dipolar couplings.

Authors:  Victoria A Higman; Jonathan Boyd; Lorna J Smith; Christina Redfield
Journal:  J Biomol NMR       Date:  2004-11       Impact factor: 2.835

3.  Crystallization and halide phasing of the C-terminal domain of human KIN17.

Authors:  Albane le Maire; Marc Schiltz; Sandrine Braud; Muriel Gondry; Jean-Baptiste Charbonnier; Sophie Zinn-Justin; Enrico Stura
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-02-10

4.  The inverse and direct Hofmeister series for lysozyme.

Authors:  Yanjie Zhang; Paul S Cremer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-21       Impact factor: 11.205

5.  Effective charge measurements reveal selective and preferential accumulation of anions, but not cations, at the protein surface in dilute salt solutions.

Authors:  Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Vladimir Razinkov; Susan F Chase; Thomas M Laue; David N Brems
Journal:  Protein Sci       Date:  2011-03       Impact factor: 6.725

6.  Flexibility of the "rigid" classics or rugged bottom of the folding funnels of myoglobin, lysozyme, RNase A, chymotrypsin, cytochrome c, and carboxypeptidase A1.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2017-10-16

7.  Chemical conversion of cisplatin and carboplatin with histidine in a model protein crystallized under sodium iodide conditions.

Authors:  Simon W M Tanley; John R Helliwell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-08-29       Impact factor: 1.056

8.  Conformational diversity facilitates antibody mutation trajectories and discrimination between foreign and self-antigens.

Authors:  Deborah L Burnett; Peter Schofield; David B Langley; Jennifer Jackson; Katherine Bourne; Emily Wilson; Benjamin T Porebski; Ashley M Buckle; Robert Brink; Christopher C Goodnow; Daniel Christ
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-27       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.